HEADER OXIDOREDUCTASE 20-SEP-12 4BB6 TITLE FREE-WILSON AND STRUCTURAL APPROACHES TO CO-OPTIMISING HUMAN AND TITLE 2 RODENT ISOFORM POTENCY FOR 11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 TITLE 3 11B-HSD1 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,11-DH, 11-BETA-HSD1, COMPND 5 11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1; COMPND 6 EC: 1.1.1.146; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, BHSD EXPDTA X-RAY DIFFRACTION AUTHOR F.W.GOLDBERG,A.G.LEACH,J.S.SCOTT,W.L.SNELSON,S.D.GROOMBRIDGE, AUTHOR 2 C.S.DONALD,S.N.L.BENNETT,C.BODIN,P.MORENTIN GUTIERREZ,A.C.GYTE REVDAT 3 08-MAY-24 4BB6 1 REMARK REVDAT 2 26-DEC-12 4BB6 1 JRNL REVDAT 1 28-NOV-12 4BB6 0 JRNL AUTH F.W.GOLDBERG,A.G.LEACH,J.S.SCOTT,W.L.SNELSON, JRNL AUTH 2 S.D.GROOMBRIDGE,C.S.DONALD,S.N.L.BENNETT,C.BODIN, JRNL AUTH 3 P.MORENTIN GUTIERREZ,A.C.GYTE JRNL TITL FREE-WILSON AND STRUCTURAL APPROACHES TO CO- OPTIMISING JRNL TITL 2 HUMAN AND RODENT ISOFORM POTENCY FOR 11BETA-HYDROXYSTEROID JRNL TITL 3 DEHYDROGENASE TYPE 1 (11BETA-HSD1) INHIBITORS JRNL REF J.MED.CHEM. V. 55 10652 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 23153367 JRNL DOI 10.1021/JM3013163 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0061 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 28890 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1533 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.62 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2010 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.3620 REMARK 3 BIN FREE R VALUE SET COUNT : 112 REMARK 3 BIN FREE R VALUE : 0.4180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4010 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 159 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.06000 REMARK 3 B22 (A**2) : 2.06000 REMARK 3 B33 (A**2) : -3.09000 REMARK 3 B12 (A**2) : 1.03000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.353 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.274 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.203 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.303 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4249 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2806 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5766 ; 1.581 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6758 ; 0.993 ; 2.998 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 522 ; 6.528 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 154 ;37.507 ;23.701 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 740 ;18.333 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;22.661 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 683 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4545 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 798 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2594 ; 0.605 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1070 ; 0.129 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4168 ; 1.164 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1655 ; 1.802 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1598 ; 2.856 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 26 A 291 5 REMARK 3 1 B 26 B 283 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1525 ; 0.39 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 1525 ; 0.39 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 1785 ; 0.66 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 B (A): 1785 ; 0.66 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1525 ; 0.48 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 1525 ; 0.48 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 1785 ; 0.60 ; 10.00 REMARK 3 LOOSE THERMAL 1 B (A**2): 1785 ; 0.60 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 26 A 291 REMARK 3 ORIGIN FOR THE GROUP (A): -7.5256 53.5477 30.1178 REMARK 3 T TENSOR REMARK 3 T11: -0.2098 T22: -0.0447 REMARK 3 T33: -0.1434 T12: -0.1285 REMARK 3 T13: -0.0197 T23: -0.0442 REMARK 3 L TENSOR REMARK 3 L11: 1.0124 L22: 1.4980 REMARK 3 L33: 2.2821 L12: -0.4381 REMARK 3 L13: 0.3157 L23: -0.5001 REMARK 3 S TENSOR REMARK 3 S11: 0.0782 S12: -0.0438 S13: -0.0135 REMARK 3 S21: 0.0408 S22: 0.1079 S23: -0.0283 REMARK 3 S31: -0.0567 S32: 0.0919 S33: -0.1861 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BB6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1290054161. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.072 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28890 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 21.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 10.10 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.25700 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.51400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 90.51400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.25700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 PHE A 3 REMARK 465 MET A 4 REMARK 465 LYS A 5 REMARK 465 LYS A 6 REMARK 465 TYR A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 PRO A 10 REMARK 465 ILE A 11 REMARK 465 LEU A 12 REMARK 465 GLY A 13 REMARK 465 LEU A 14 REMARK 465 PHE A 15 REMARK 465 MET A 16 REMARK 465 ALA A 17 REMARK 465 TYR A 18 REMARK 465 TYR A 19 REMARK 465 TYR A 20 REMARK 465 TYR A 21 REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 465 ASN A 24 REMARK 465 GLU A 25 REMARK 465 LYS A 292 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 PHE B 3 REMARK 465 MET B 4 REMARK 465 LYS B 5 REMARK 465 LYS B 6 REMARK 465 TYR B 7 REMARK 465 LEU B 8 REMARK 465 LEU B 9 REMARK 465 PRO B 10 REMARK 465 ILE B 11 REMARK 465 LEU B 12 REMARK 465 GLY B 13 REMARK 465 LEU B 14 REMARK 465 PHE B 15 REMARK 465 MET B 16 REMARK 465 ALA B 17 REMARK 465 TYR B 18 REMARK 465 TYR B 19 REMARK 465 TYR B 20 REMARK 465 TYR B 21 REMARK 465 SER B 22 REMARK 465 ALA B 23 REMARK 465 ASN B 24 REMARK 465 GLU B 25 REMARK 465 TYR B 284 REMARK 465 ASN B 285 REMARK 465 TRP B 286 REMARK 465 ASP B 287 REMARK 465 ARG B 288 REMARK 465 PHE B 289 REMARK 465 ILE B 290 REMARK 465 ASN B 291 REMARK 465 LYS B 292 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 285 CG OD1 ND2 REMARK 470 TRP A 286 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 286 CZ3 CH2 REMARK 470 PHE A 289 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 65 176.12 166.47 REMARK 500 ASN A 119 -23.04 -140.55 REMARK 500 HIS A 130 -71.12 -110.05 REMARK 500 ASP A 131 12.49 -141.20 REMARK 500 LEU A 179 3.71 82.12 REMARK 500 VAL A 180 33.57 -143.75 REMARK 500 ASP A 219 37.32 -77.09 REMARK 500 VAL A 231 103.86 -31.18 REMARK 500 GLN A 234 96.95 -1.19 REMARK 500 ARG A 288 -71.75 -38.99 REMARK 500 ILE A 290 116.64 88.28 REMARK 500 ALA B 65 -174.18 161.98 REMARK 500 HIS B 130 -70.63 -133.84 REMARK 500 PHE B 144 -63.01 -128.71 REMARK 500 LEU B 179 6.42 80.97 REMARK 500 VAL B 180 42.70 -144.11 REMARK 500 ASN B 207 48.64 -92.57 REMARK 500 ASP B 219 38.46 -76.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 1292 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HD1 A 1293 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1294 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 1284 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HD1 B 1285 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XU7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE INTERFACE OPEN CONFORMATION OFTETRAMERIC REMARK 900 11B-HSD1 REMARK 900 RELATED ID: 1XU9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE INTERFACE CLOSED CONFORMATION OF11B- REMARK 900 HYDROXYSTEROID DEHYDROGENASE ISOZYME 1 REMARK 900 RELATED ID: 2BEL RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX REMARK 900 WITH NADP AND CARBENOXOLONE REMARK 900 RELATED ID: 4BB5 RELATED DB: PDB REMARK 900 FREE-WILSON AND STRUCTURAL APPROACHES TO CO-OPTIMISING HUMAN AND REMARK 900 RODENT ISOFORM POTENCY FOR 11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1 REMARK 900 11B-HSD1 INHIBITORS DBREF 4BB6 A 1 292 UNP P28845 DHI1_HUMAN 1 292 DBREF 4BB6 B 1 292 UNP P28845 DHI1_HUMAN 1 292 SEQADV 4BB6 LEU A 179 UNP P28845 MET 179 CONFLICT SEQADV 4BB6 ARG A 262 UNP P28845 LEU 262 CONFLICT SEQADV 4BB6 SER A 272 UNP P28845 CYS 272 CONFLICT SEQADV 4BB6 GLU A 278 UNP P28845 PHE 278 CONFLICT SEQADV 4BB6 TRP A 286 UNP P28845 MET 286 CONFLICT SEQADV 4BB6 LEU B 179 UNP P28845 MET 179 CONFLICT SEQADV 4BB6 ARG B 262 UNP P28845 LEU 262 CONFLICT SEQADV 4BB6 SER B 272 UNP P28845 CYS 272 CONFLICT SEQADV 4BB6 GLU B 278 UNP P28845 PHE 278 CONFLICT SEQADV 4BB6 TRP B 286 UNP P28845 MET 286 CONFLICT SEQRES 1 A 292 MET ALA PHE MET LYS LYS TYR LEU LEU PRO ILE LEU GLY SEQRES 2 A 292 LEU PHE MET ALA TYR TYR TYR TYR SER ALA ASN GLU GLU SEQRES 3 A 292 PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE VAL SEQRES 4 A 292 THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA TYR SEQRES 5 A 292 HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR ALA SEQRES 6 A 292 ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS CYS SEQRES 7 A 292 LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA GLY SEQRES 8 A 292 THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL ALA SEQRES 9 A 292 GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU ILE SEQRES 10 A 292 LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE HIS SEQRES 11 A 292 ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL ASN SEQRES 12 A 292 PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU PRO SEQRES 13 A 292 MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SER SEQRES 14 A 292 SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA ALA SEQRES 15 A 292 TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SER SEQRES 16 A 292 SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN VAL SEQRES 17 A 292 SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR GLU SEQRES 18 A 292 THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET GLN SEQRES 19 A 292 ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS SEQRES 20 A 292 GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SER SEQRES 21 A 292 SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER ARG SEQRES 22 A 292 LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN TRP SEQRES 23 A 292 ASP ARG PHE ILE ASN LYS SEQRES 1 B 292 MET ALA PHE MET LYS LYS TYR LEU LEU PRO ILE LEU GLY SEQRES 2 B 292 LEU PHE MET ALA TYR TYR TYR TYR SER ALA ASN GLU GLU SEQRES 3 B 292 PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE VAL SEQRES 4 B 292 THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA TYR SEQRES 5 B 292 HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR ALA SEQRES 6 B 292 ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS CYS SEQRES 7 B 292 LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA GLY SEQRES 8 B 292 THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL ALA SEQRES 9 B 292 GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU ILE SEQRES 10 B 292 LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE HIS SEQRES 11 B 292 ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL ASN SEQRES 12 B 292 PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU PRO SEQRES 13 B 292 MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SER SEQRES 14 B 292 SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA ALA SEQRES 15 B 292 TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SER SEQRES 16 B 292 SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN VAL SEQRES 17 B 292 SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR GLU SEQRES 18 B 292 THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET GLN SEQRES 19 B 292 ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS SEQRES 20 B 292 GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SER SEQRES 21 B 292 SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER ARG SEQRES 22 B 292 LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN TRP SEQRES 23 B 292 ASP ARG PHE ILE ASN LYS HET NAP A1292 48 HET HD1 A1293 31 HET CL A1294 1 HET NAP B1284 48 HET HD1 B1285 31 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM HD1 6-(4-METHYLPIPERAZIN-1-YL)-N-[(1R,3S)-5-OXIDANYL-2- HETNAM 2 HD1 ADAMANTYL]-2-PROPYLSULFANYL-PYRIDINE-3-CARBOXAMIDE HETNAM CL CHLORIDE ION HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 HD1 2(C24 H36 N4 O2 S) FORMUL 5 CL CL 1- FORMUL 8 HOH *14(H2 O) HELIX 1 1 ARG A 28 GLN A 33 5 6 HELIX 2 2 LYS A 44 MET A 57 1 14 HELIX 3 3 SER A 67 GLY A 82 1 16 HELIX 4 4 ASP A 95 GLY A 111 1 17 HELIX 5 5 ASP A 132 PHE A 144 1 13 HELIX 6 6 PHE A 144 ASN A 162 1 19 HELIX 7 7 ALA A 172 LYS A 174 5 3 HELIX 8 8 VAL A 180 SER A 204 1 25 HELIX 9 9 THR A 220 SER A 228 1 9 HELIX 10 10 PRO A 237 ARG A 252 1 16 HELIX 11 11 SER A 261 ARG A 269 1 9 HELIX 12 12 ASN A 270 ASN A 285 1 16 HELIX 13 13 ARG B 28 GLN B 33 5 6 HELIX 14 14 LYS B 44 MET B 57 1 14 HELIX 15 15 SER B 67 GLY B 82 1 16 HELIX 16 16 ASP B 95 GLY B 111 1 17 HELIX 17 17 ASP B 132 PHE B 144 1 13 HELIX 18 18 PHE B 144 ASN B 162 1 19 HELIX 19 19 ALA B 172 LYS B 174 5 3 HELIX 20 20 VAL B 180 SER B 204 1 25 HELIX 21 21 THR B 220 VAL B 227 1 8 HELIX 22 22 SER B 228 ALA B 235 5 8 HELIX 23 23 PRO B 237 LEU B 251 1 15 HELIX 24 24 SER B 261 ARG B 269 1 9 HELIX 25 25 ASN B 270 THR B 282 1 13 SHEET 1 AA 7 SER A 85 ALA A 90 0 SHEET 2 AA 7 HIS A 60 ALA A 65 1 O VAL A 61 N HIS A 87 SHEET 3 AA 7 LYS A 36 VAL A 39 1 O VAL A 37 N VAL A 62 SHEET 4 AA 7 MET A 115 LEU A 118 1 O MET A 115 N ILE A 38 SHEET 5 AA 7 SER A 164 SER A 170 1 O SER A 164 N LEU A 116 SHEET 6 AA 7 SER A 209 LEU A 215 1 O SER A 209 N ILE A 165 SHEET 7 AA 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 BA 7 SER B 85 ALA B 90 0 SHEET 2 BA 7 HIS B 60 ALA B 65 1 O VAL B 61 N HIS B 87 SHEET 3 BA 7 LYS B 36 VAL B 39 1 O VAL B 37 N VAL B 62 SHEET 4 BA 7 MET B 115 LEU B 118 1 O MET B 115 N ILE B 38 SHEET 5 BA 7 SER B 164 SER B 170 1 O SER B 164 N LEU B 116 SHEET 6 BA 7 SER B 209 LEU B 215 1 O SER B 209 N ILE B 165 SHEET 7 BA 7 GLU B 255 TYR B 258 1 O VAL B 256 N VAL B 214 SITE 1 AC1 26 GLY A 41 SER A 43 LYS A 44 GLY A 45 SITE 2 AC1 26 ILE A 46 ARG A 66 SER A 67 GLY A 91 SITE 3 AC1 26 THR A 92 MET A 93 ASN A 119 HIS A 120 SITE 4 AC1 26 ILE A 121 VAL A 168 SER A 169 SER A 170 SITE 5 AC1 26 TYR A 183 LYS A 187 LEU A 215 GLY A 216 SITE 6 AC1 26 LEU A 217 ILE A 218 THR A 220 THR A 222 SITE 7 AC1 26 ALA A 223 HD1 A1293 SITE 1 AC2 8 ILE A 121 LEU A 126 SER A 170 TYR A 183 SITE 2 AC2 8 LEU A 217 MET A 233 NAP A1292 TYR B 280 SITE 1 AC3 1 GLU A 221 SITE 1 AC4 26 GLY B 41 SER B 43 LYS B 44 GLY B 45 SITE 2 AC4 26 ILE B 46 ALA B 65 ARG B 66 SER B 67 SITE 3 AC4 26 THR B 92 MET B 93 ASN B 119 HIS B 120 SITE 4 AC4 26 ILE B 121 VAL B 168 SER B 169 SER B 170 SITE 5 AC4 26 TYR B 183 LYS B 187 LEU B 215 GLY B 216 SITE 6 AC4 26 LEU B 217 ILE B 218 THR B 220 THR B 222 SITE 7 AC4 26 ALA B 223 HD1 B1285 SITE 1 AC5 8 TYR A 280 ILE B 121 SER B 170 LEU B 171 SITE 2 AC5 8 TYR B 177 TYR B 183 THR B 222 NAP B1284 CRYST1 108.651 108.651 135.771 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009204 0.005314 0.000000 0.00000 SCALE2 0.000000 0.010628 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007365 0.00000 MTRIX1 1 0.214700 0.743800 0.632900 -64.52000 1 MTRIX2 1 0.740000 -0.546800 0.391600 76.44000 1 MTRIX3 1 0.637400 0.384300 -0.667900 33.82000 1